GCCL(Global Clinical Central Lab)

???[#Blog/?????????????????????? ????????????] ???????????? ???????????????????? ?????? ?????????????????????? ?????????? ?????????????? (??) To provide a deeper understanding of calibration curve fitting, GCCL(Global Clinical Central Lab) has launched a dedicated blog series?exploring statistical approaches to calibration curve fitting. In our previous post, we covered the concept of linear regression, its common assumptions, advantages and disadvantages,?along with?calibration curve fitting?for linear regression. This time, Dr. Kyungmin In, our R&D Unit Leader, introduces linear regression analysis on Regression Model Fit Assessment, etc. Check out the second post and stay tuned for the next article in the series! ?? Read the blog post here: https://lnkd.in/gJVc9nun #ClinicalResearch #Bioanalysis #CalibrationCurve #Statistics #Article #linearregression #CentralLab #ClinicalLab #Clinicaltrials

??????????????????????? ???? ??????????????, ???????????? ???? ?????????????????????????? We are excited to share that our?ISO 15189 accreditation?(KOLAS Accredited Medical Testing Laboratory) has been extended for another?four years, now valid through?2029! ISO 15189 accreditation is a globally recognized standard that ensures?technical competence, reliability, and quality management?in medical laboratory testing.?This renewal reflects our dedication to rigorous quality standards, ensuring the highest reliability in clinical sample analysis. At GCCL, quality is not just a requirement—it’s our foundation for advancing global clinical research. ?? #ISO15189 #Accreditation #ClinicalResearch #QualityFirst #CentralLab #ClinicalLab #DrugDevelopment #ClinicalTrials

??? 2025 2nd GCCL Webinar Cell-based potency assays play a crucial role in evaluating the quality and efficacy of biopharmaceuticals. In this webinar, Yoonki Kim, Team Leader of Research Team 1 at GCCL(Global Clinical Central Lab), will share insights into the development and validation of cell-based bioassays for biopharmaceuticals. Leveraging his deep knowledge and experience in PK and immunogenicity assay development for protein therapeutics, bioanalytical method development and technology transfer, in vitro screening process establishment, candidate discovery, and MoA/efficacy studies, Mr. Kim will kindly offer his perspectives on critical considerations for assay development. ?? When: March 26, 2025 (Wednesday), 2:00 PM - 3:00 PM (KST) ?? Who: Yoonki Kim, Team Leader of Research Team 1 at GCCL ?? How: Pre-register by clicking the link - https://naver.me/xWT02gKU

??????????? ???? ?????? ???????????? ???????????? ???????? – ???????? ???? ???? ??????????! We’re excited to participate in #BIOEUROPE Spring, from?March 17-19?in Milan! As a leading central lab in APAC, GCCL(Global Clinical Central Lab) provides comprehensive?clinical sample analysis?and?bioanalytical services?to support global clinical trials. Our CEO will also attend, and we look forward to engaging with industry leaders and partners. If you're looking for a reliable lab partner for your next clinical program, we’d love to connect. Looking forward to insightful discussions—see you in Milan! ?? ???Request a meeting here: https://lnkd.in/gsqAX8Ft ????March 17-19, 2025 ???Milano(Allianz MiCo), Italy ???Email: [email protected] #BIOEuropeSpring #BIO #ClinicalTrials #CentralLab #Pharmaceutical #Biotech #Innovation #Healthcare #Partnering

???[#Blog/?????????????????????? ????????????] ???????????? ???????????????????? ?????? ?????????????????????? ?????????? ?????????????? Calibration curve fitting is a fundamental concept in?quantitative bioanalysis, ensuring precision and accuracy in method validation. To provide a deeper understanding,?GCCL(Global Clinical Central Lab) has launched a dedicated blog series?exploring statistical approaches to calibration curve fitting. Dr. Kyungmin In, our R&D Unit Leader, introduces Linear Regression Curve Fitting, covering its application in bioanalytical method development. The series will also explore non-linear regression techniques commonly used in LBA/CBA analysis, along with statistical principles and R-based modeling. Check out the first post and stay tuned for the next article in the series! ?? Read the blog post here: https://lnkd.in/gPv7EEmH #ClinicalResearch #Bioanalysis #CalibrationCurve #Statistics #linearregression #CentralLab #ClinicalLab #Clinicaltrials

?? ???????????????????? ???????? ???????????????? ???????????? ???????? ????????’?? ?????????????? ?????? ????????????????! We are excited to introduce our latest #brochure, showcasing GCCL(Global Clinical Central Lab)’s comprehensive?central lab services?designed to streamline?multi-national and multi-site clinical trials. With our?integrated system, we ensure?efficiency, consistency, and high-quality data management?across all phases of clinical research. Discover how our central lab solutions can support your clinical trial success.?Download the brochure now! ???Global Network & Quality Assurance - 10+ years of experience across 15+ countries - Global QC standardization for consistent results - ISO 15189, CAP, NGSP, ISBER accredited ???Comprehensive Lab Capabilities - Clinical Lab | Bio-analytical Lab | R&D Lab - Biomarker profiling, PBMC isolation, genetic testing - Safety & efficacy testing across multiple disciplines ???End-to-End Sample & Logistics Management - Lab Kit production & Bio-Logistics services - Sample storage & biorepository - Real-time tracking via our in-house?G-HUB system #ClinicalTrials #CentralLab #Bioanalysis #Biomarkers #ClinicalLab #DrugDevelopment #ProjectManagement #PBMC #Lab

GCCL(Global Clinical Central Lab), a joint venture of GC Labs and GC Cell, has launched Korea's first commercial biomarker analysis service for #Parkinson’s disease. https://lnkd.in/g_4MegW6

#NEWS We are proud to announce that GCCL has launched Korea’s first clinical biomarker analysis service(α??????-??????) for Parkinson’s disease! ?? With our proprietary αSyn-SAA (α-synuclein Seed Amplification Assay) method, we are bringing a global-level biomarker analysis to support neurodegenerative disease research and diagnostics. Our cutting-edge technology enables precise detection of abnormal α-syn in CSF, enhancing research in PD, multiple system atrophy, Lewy body dementia, and other CNS disorders. This achievement is led by our dedicated R&D team, including Dr. Jaewook Hyeon, Team Manager, and Senior Researcher Minyoung Kim, who have successfully developed and validated the αSyn-SAA method. Huge thanks to their hard work and dedication! ?? ?? Read the full press release: https://lnkd.in/g3fj9uFh #PressRelease #ClinicalTrials #CentralLab #ParkinsonsDisease #Biomarker #Neuroscience #neurodegenerative #DrugDevelopment #CNS #Healthcare

?? Discover GCCL(Global Clinical Central Lab) Lab at a Glance! We’re excited to introduce the GCCL Lab for clinical trial – your interactive way to explore GCCL Lab! ???Interactive Map - Click through the map to get a closer look at each facility. ?? Lab Tour Video – Experience the lab as if you were there! ?? Check it out now! Map: https://lnkd.in/gVF9sH4S Video: https://lnkd.in/gPnnYXqu #GCCL #ClinicalTrials #CentralLab #Pharmaceutical #Biotech #DrugDevelopment #Oncology #Healthcare #Biotechnology

GCCL(Global Clinical Central Lab), a leading Korean clinical trial sample analysis company, has strengthened its global presence by receiving Frost & Sullivan’s 2025 Best Practices Customer Value Leadership Award in the Asia-Pacific clinical sample analysis services industry. GCCL provides clinical trial sample analysis across all phases (I-IV), utilizing advanced platforms like ddPCR. It ensures fast sample transport with same-day delivery in Korea and global shipping through trusted partners, offering customized solutions for pharma and biotech companies worldwide. Read more: https://lnkd.in/g_wMu_XN